WBBA Events in Review
The latest in life sciences.
Life Sciences Leadership Summit
May 23, 2013 Washington State University, Spokane
This year's Leadership Summit in Spokane was one for the record books. We had a record number of attendees (nearly 120) and a record number of sponsors (8). We were thrilled to again partner with WSU Spokane to bring together a program with speakers from the Greater Spokane area – including welcome from Mayor David Condon; a keynote address from K. Michael Gibson, PhD from Washington State University; and updates from some of Spokane’s prolific and up-and-coming organizations. The event didn’t stop there! We had updates from LSDF, Washington State Department of Commerce, Western Washington organizations, and the SBA. It was a half-day filled with great presentations and great discussion - capped off with lively town hall forum moderated by Chris Rivera. The event ended with a networking reception – in true WBBA fashion. Thanks again to our sponsors for helping us bring this very important meeting to our members and future members alike. Sponsors included: INHS, Jubilant HollisterStier, Lee & Hayes, MPI Research, PAML, Washington State University, We Work for Health and ZymoGenetics.
Pictured: Mike Livingston, Chairman, University District Public Development Authority; Brett Nelson, Partner, Lee & Hayes; Francisco R. Velàzquez, MD, SM, President and Chief Executive Officer, Pathology Associates Medical Laboratories (PAML); Lisa Cohen, Executive Director, Washington Global Health Alliance; Thong Le, Executive Director, WRF Capital; Charles V. Baltic III, Managing Director; Co-Head of Life Sciences, Needham, & Company, LLC; Dennis Dyck, PhD, Professor of Psychology, Washington State University; Lisa Shaffer, PhD, Founder, Genetic Veterinary Sciences (Paw Print Genetics)
VIP Plenary with J&J Development Corp.
May 16-17, 2013 Agora Conference Center
In May we welcomed business development leadership from Johnson & Johnson Development Corporation (JJDC) to Seattle for our most recent VIP Forum. Johnson & Johnson is a well-known global giant in the health sector. Johnson & Johnson Development Corporation, the venture capital subsidiary of J&J, invests in life science and technology businesses that focus on traditional healthcare sectors such as pharmaceuticals, companion diagnostics, and medical devices. The JJDC executives also met with earlier stage research groups and companies on behalf of Johnson & Johnson Innovation, which focuses on identifying early-stage innovation at academic institutions, start-up biotech companies and venture capital firms, and provide integrated capabilities to scout, evaluate, fund, guide, and onboard new science. To learn more about the evening, click here
VIP Forums are generously supported by Cooley LLP, PriceWaterhouseCoopers and Knobbe Martens. If your organization is interested in sponsoring a VIP Forum, information can be found in the WBBA’s Sponsorship Prospectus.
Breakfast @ BIO with Washington State Department of Commerce
April 23, 2013 BIO International Convention, Chicago
It was standing room only at the BIO breakfast hosted by the Washington State Department of Commerce at the Intercontinental Hotel on Chicago’s infamous Magnificent Mile. Hovan Asdourian from Commerce gave a brief welcome to the crowd while Chris Rivera provided an overview of the Life Sciences landscape in Washington. Guests networked before and after this event and enjoyed getting together at BIO. Just goes to show, you never know where you can connect with the WBBA!
WBBA’s Pub Night, Bellevue Brewery
April 18, 2013 Bellevue Brewing Company
It was a packed house at the tucked away beer mecca of Bellevue Brewery for our spring pub night! Beer enthusiasts and wine lovers alike found this industrial and modern brewery a great place to meet and greet with Life Sciences executives, job seekers, members, and future members. Business cards were dropped and prizes were given away at this fantastic quarterly event! Stay tuned for our next twist on Pub Night – our showing of the film Extraordinary Measures featuring the story of LSINW keynote speaker, John Crowley, CEO of Amicus Therapeutics. Thanks to ZymoGenetics for sponsoring; more opportunities for sponsorship are available; please contact Dennis Kroft.
WBBA Training Symposium
April 17, 2013 Agora Conference Center
The WBBA Hosted the first ever Training Symposium in April featuring six WBBA member organizations including: The Leadership Edge, ETI Group, Ingenium, University of Washington Professional & Continuing Education, Northeastern University, Seattle, and Washington State University (Professional Science Master’s (PSM). The goal of the event was to educate the WBBA HR professionals about the opportunities our members can offer. The event delivered, and content from the event was captured by video! Stay tuned for updates on what our training partners spoke about and can off YOUR organization.
Mobile Health: In the Market, In the Lab and In Between
April 10, 2013 Orin Smith Auditorium, SLU
Leaders in global health gathered at South Lake Union to discuss current issues facing the process of developing technologies to improve the wellbeing of people and communities around the world. Paul Yager (Chair of the Bioengineering Department at UW) introduced the program, discussing the current state of health IT and highlighting the need for an integration of all health information to reconnect diagnostics and therapy. Read more about the event here!
Washington as an Antibody Hub
April 10, 2013 Washington State Convention Center
The event opened with an overview of the Antibody Hub landscape of the Pacific Northwest from Dr. Steve Gillis, Managing Director of ARCH Venture Partners – the idea behind this innovative program. The lineup of speakers was a "who’s who" in the Antibody Hub space and the content, discussion and energy was second to none. Read more about the event here! A special thanks to our many sponsors of this event: Alder Biopharmaceuticals, ARCH Venture Partners, CMC Biologics, Fenwick & West, LLP, MPI Research, Paraxel, Seattle Genetics, SNBL USA, Tandem Labs, and Theraclone Sciences.
Non-Dilutive Funding: Finding It, Getting It, and Using It Strategically to Move Your Company Forward
For early stage life sciences companies, securing non-dilutive funding can provide working capital for crucial experimentation while allowing company founders to maintain control of the company, and provide external validation of an emerging technology and team. The WBBA event Non-Dilutive Funding: Finding It, Getting It, and Using It Strategically to Move Your Company Forward focused on sources, challenges, strategies and support around the process of securing non-dilutive funding. Read more about the event here!
Return to top
Learn more about ALL OF WBBA's past events in the online Events Archives.
Do you have a conference room or meeting facility and would like to host a WBBA event?
Please contact WBBA's Associate Director of Events, Darcy Jacobson.
Return to newsletter main page